Multipl Secures $1.5 Million in Additional Funds, Led by Blume Ventures and MIXI Global Investments, Japan

▴ Multipl
Multipl does have a great value proposition rewarding wise consumers with dual benefits from investment and discounts. The app encourages you to go for your aspirational spending and at the same time helps you maintain a healthy habit of saving.

Bengaluru, India, July 17th, 2024:  Multipl, a new-age SEBI registered fintech platform that integrates investing and spending through its innovative ‘Spendvesting’ concept, announced that the company has raised additional funding of $1.5 million led by Blume Ventures and MIXI Global Investments, Inc.

The capital raised will be deployed towards making platform enhancements and introduction of disruptive features thereby helping more Indians start their Spendvesting journeys. 

While there is a sharp growth in Indians participating in mutual fund investments, this has primarily been towards long-term wealth creation needs or for pure-play investments purposes. Multipl, with its integration with mutual funds and partnerships with top brands, is now enabling consumers to invest in mutual funds for their lifestyle spends. This unique concept seamlessly integrates investing and spending, setting a new standard in financial management. By empowering individuals to invest small amounts in mutual funds regularly for future expenditures and by bringing brands to reward customer loyalty, Multipl makes lifestyle spends with brands more beneficial and fun. 

Upon the announcement, Paddy Raghavan, Co-Founder of Multipl, commented, “The support from Blume and MIXI Japan will help us enhance the product experience and bring more awareness to the Spendvesting category that we are creating.  This round of funding empowers us to drive forward our mission of helping Indians live an aspirational life in a financially prudent manner”. 

“We are excited about the opportunity to support Multipl’s innovative approach to personal finance. Spend-based investing represents a significant evolution in how individuals can manage and grow their savings. Our continued investment reflects our confidence in Multipl’s potential to create lasting value for its users,” said Ashish Fafadia, partner at Blume Ventures, in the announcement.

Tomoharu Urabe, Principal Partner at MIXI Global Investments, Inc., said, “Multipl does have a great value proposition rewarding wise consumers with dual benefits from investment and discounts.  The app encourages you to go for your aspirational spending and at the same time helps you maintain a healthy habit of saving.  We are excited to be a part in this journey of building a personal finance solution for the cycle of saving, investing and spending.”

Since its establishment in 2020, Multipl has achieved significant milestones, including over 500,000 downloads, forming more than 100 valuable brand partnerships, and facilitating goals valued at over ?1000 crores. Multipl continues to innovate with recent introductions such as 'Open Goals,' enabling users to invest in unforeseen future expenses through partnerships with leading brands. The Window Shopper widget further enhances consumer savings by seamlessly embedding options for financial planning at the point of purchase across merchant websites and apps. 


About Multipl:
Established in 2020 by Paddy Raghavan, Jags Raghavan, and Vikas Jain, Multipl stands as the foremost global platform dedicated to Spendvesting. It has emerged as a category creator by bringing together the gratification of spending with the benefits of investment. Short-term recurring investments in assets like mutual funds advised by SEBI registered in-house experts, combined with an added contribution from partner brands, have resulted in a dual benefit model yielding unmatched value to its customer

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Healthcare Trends in 2026: What India's Doctors, Hospitals, and Patients Need to KnowJuly 18, 2026
Monsoon Health Problems in India: Understanding the Risks, Symptoms, and PreventionJuly 18, 2026
Fortis Escorts Faridabad Launches Faridabad’s First Comprehensive Lung Failure Clinic for Advanced Respiratory and Transplant CareJuly 17, 2026
What Seemed Like Persistent Gas Turned Out To Be A 30-cm Rare Cancer Occupying Most Of Her AbdomenJuly 17, 2026
Kidney Stone Prevention Initiative Unites More Than 8,200 Doctors Across India, Earns Asia Book of Records RecognitionJuly 17, 2026
Moscow radiologists introduce AI tool for hip dysplasia diagnosisJuly 17, 2026
Sharrp Ventures leads 100 CR investment in Naturis Cosmetics’ first institutional funding roundJuly 17, 2026
Eugenix Challenges Hair Loss Stigma With Nationwide 'I Chose Transformation' Campaign Featuring Boney KapoorJuly 17, 2026
How Artificial Intelligence is Reshaping Preventive Healthcare Through Earlier Detection and Smarter Clinical InsightsJuly 17, 2026
Five Common Myths About Children's Urinary Problems That Parents Should Stop BelievingJuly 17, 2026
Robotics in Surgery: How Robot-Assisted Procedures Are Transforming Healthcare in IndiaJuly 17, 2026
Wearable Health Devices: How Smart Technology Is Changing Healthcare in IndiaJuly 17, 2026
Sankara Eye Hospitals Successfully Hosts 20th Annual VISION 2020 India Conference, Celebrating 50 Years of the Sankara MovementJuly 16, 2026
Manipal Hospital Bhubaneswar Successfully Treats Rare Brain Injury Caused by Post-Traumatic Workplace AccidentJuly 16, 2026
Immuneel Therapeutics and Tata Memorial Centre Sign Strategic MoU to Advance Cell and Gene Therapy Research in India July 16, 2026
Breast Cancer Early Warning Signs: What Every Woman in India Needs to KnowJuly 16, 2026
HbA1c Test Explained: What It Measures, Normal Range, and Why It Matters for IndiansJuly 16, 2026
Not Just Weight Loss: How Bariatric Surgery Improves Diabetes, PCOS, and Thyroid-Related Health ChallengesJuly 15, 2026
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety DisordersJuly 15, 2026
Dr Agarwals Institute of Optometry and SASTRA University Jointly Launch Optometry ProgrammeJuly 15, 2026